Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease - EP3097923

The patent EP3097923 was granted to Yeda Research on Jul 27, 2022. The application was originally filed on Jan 31, 2008 under application number EP16177278A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3097923

YEDA RESEARCH
Application Number
EP16177278A
Filing Date
Jan 31, 2008
Status
Granted And Under Opposition
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSApr 27, 2023GREGSONADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2002137697
DESCRIPTIONUS5906936
DESCRIPTIONUS5912172
DESCRIPTIONWO0031239
DESCRIPTIONWO9319163
DESCRIPTIONWO9514710
DESCRIPTIONWO9715669
EXAMINATIONUS2003147865
OPPOSITIONEP1795599
OPPOSITIONUS2002137697
OPPOSITIONUS2003015057
OPPOSITIONUS2003147865
OPPOSITIONWO02072796
OPPOSITIONWO03066072
OPPOSITIONWO2007065957
OPPOSITIONWO9319163
OTHEREP2126054

Non-Patent Literature (NPL) Citations (147) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AKASHI S ET AL., J. EXP. MED., (2003), vol. 198, pages 1035 - 1042-
DESCRIPTION- AMATI L ET AL., CURR PHARM DES., (2003), vol. 9, pages 1937 - 1945-
DESCRIPTION- ASANO M ET AL., JEXP MED, (1996), vol. 184, pages 387 - 396-
DESCRIPTION- ASHKENAZI A ET AL., INT REV IMMUNOL., (1993), vol. 10, pages 219 - 227-
DESCRIPTION- BAXEVANIS CN ET AL., CANCER IMMUNOL IMMUNOTHER, (2004), vol. 53, pages 893 - 903-
DESCRIPTION- BECKER C ET AL., GUT, (2005), vol. 54, pages 950 - 954-
DESCRIPTION- BEECHAM EJ ET AL., JIMMUNOTHER, (2000), vol. 23, pages 631 - 642-
DESCRIPTION- BEIDER K ET AL., BLOOD, (2003), vol. 102, pages 1951 - 1958-
DESCRIPTION- BENNETT F ET AL., J IMMUNOL., (2003), vol. 170, pages 711 - 718-
DESCRIPTION- BHAN AK ET AL., IMMUNOL REV, (1999), vol. 169, pages 195 - 207-
DESCRIPTION- BITTON N ET AL., CURR TOP MICROBIOL IMMUNOL, (2001), vol. 260, pages 271 - 300-
DESCRIPTION- BLEUL CC ET AL., J EXP MED, (1996), vol. 184, pages 1101 - 1109-
DESCRIPTION- BLUMBERG RS ET AL., CURR OPIN IMMUNOL., (1999), vol. 11, pages 648 - 656-
DESCRIPTION- BOUSSIOTIS VA ET AL., IMMUNOL REV, (1996), vol. 153, pages 5 - 26-
DESCRIPTION- BROCKER T ET AL., J EXP MED, (1995), vol. 181, pages 1653 - 1659-
DESCRIPTION- CAMBIER JC, J IMMUNOL., (1995), vol. 155, pages 3281 - 3285-
DESCRIPTION- CARIO E ET AL., J IMMUNOL., (2006), vol. 176, pages 4258 - 4266-
DESCRIPTION- CHAMOW SM ET AL., INT J CANCER, (1992), vol. 7, pages 69 - 72-
DESCRIPTION- CHEN W ET AL., JEXP MED, (1998), vol. 188, pages 1849 - 1857-
DESCRIPTION- CHEUK AT ET AL., CANCER GENE THER, (2004), vol. 11, pages 215 - 226-
DESCRIPTION- CURIEL TJ ET AL., NAT MED, (2004), vol. 10, pages 942 - 949-
DESCRIPTION- DAERON M, ANNU REV IMMUNOL., (1997), vol. 15, pages 203 - 234-
DESCRIPTION- DAUPHINEE SM ET AL., LAB. INVEST., (2006), vol. 86, pages 9 - 22-
DESCRIPTION- DAVIDSON ET AL., J IMMUNOL, (1998), vol. 161, pages 3143 - 3149-
DESCRIPTION- DUDLEY ME ET AL., J IMMUNOTHER, (2001), vol. 24, pages 363 - 373-
DESCRIPTION- DUDLEY ME ET AL., SCIENCE, (2002), vol. 298, pages 850 - 854-
DESCRIPTION- EHRHARDT ET AL., J IMMUNOL, (1997), vol. 158, pages 566 - 573-
DESCRIPTION- ESHHAR Z ET AL., BR J CANCER, (1990), vol. 10, pages 27 - 29-
DESCRIPTION- ESHHAR Z ET AL., JIMM METH, (2001), vol. 248, pages 67 - 76-
DESCRIPTION- ESHHAR Z ET AL., PROC NATL ACAD SCI USA, (1993), vol. 90, pages 720 - 724-
DESCRIPTION- ESHHAR Z ET AL., SPRINGER SEMIN IMMUNOPATHOL., (1996), vol. 18, no. 2, pages 199 - 209-
DESCRIPTION- ESHHAR Z; FITZER-ATTAS CJ, ADV DRUG DELIV REV., (1998), vol. 31, pages 171 - 182-
DESCRIPTION- FANTINI MC ET AL., GUT, (2006), vol. 55, pages 671 - 680-
DESCRIPTION- FINNEY HM ET AL., J IMMUNOL, (1998), vol. 161, pages 2791 - 2797-
DESCRIPTION- FINNEY HM ET AL., J IMMUNOL, (2004), vol. 172, pages 104 - 113-
DESCRIPTION- FITZER-ATTAS CJ ET AL., JLMMUNOL., (1998), vol. 160, pages 145 - 154-
DESCRIPTION- FLASWINKEL H ET AL., SEMIN IMMUNOL., (1995), vol. 7, pages 21 - 27-
DESCRIPTION- FONTENOT JD ET AL., NAT IMMUNOL., (2003), vol. 4, pages 330 - 336-
DESCRIPTION- GROSS G; ESHHAR, Z, FASEB J, (1992), vol. 6, pages 3370 - 3378-
DESCRIPTION- GROSS G ET AL., PROC NATL ACAD SCI USA, (1989), vol. 86, pages 10024 - 10028-
DESCRIPTION- GUINN BA ET AL., J IMMUNOL, (1999), vol. 162, pages 5003 - 5010-
DESCRIPTION- HAN X ET AL., GASTROENTEROLOGY, (2005), vol. 129, pages 185 - 203-
DESCRIPTION- HONG ET AL., J IMMUNOL, (1999), vol. 162, pages 7480 - 7491-
DESCRIPTION- HORAK, CLIN IMMUNOL IMMUNOPATHOL, (1995), vol. 76, pages S172 - S173-
DESCRIPTION- HORI S ET AL., SCIENCE, (2003), vol. 299, pages 1057 - 1061-
DESCRIPTION- HUMPHREY MB ET AL., IMMUNOL REV., (200512), vol. 208, pages 50 - 65-
DESCRIPTION- ISAKOV N, J LEUKOC BIOL., (1997), vol. 61, pages 6 - 16-
DESCRIPTION- ISAKOV N, RECEPTORS CHANNELS., (1998), vol. 5, pages 243 - 253-
DESCRIPTION- JAMESON SC., NAT REV IMMUNOL, (2002), vol. 2, pages 547 - 556-
DESCRIPTION- JODI MD ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 1215 - 1220-
DESCRIPTION- JONULEIT H ET AL., JEXP MED, (2001), vol. 193, pages 1285 - 1294-
DESCRIPTION- JUNGHANS R ET AL., PROC AM ASSOC CAN RES, (2000), vol. 41, page 543-
DESCRIPTION- KASPROWICZ DJ ET AL., J IMMUNOL., (2003), vol. 171, pages 1216 - 1223-
DESCRIPTION- KERSHAW MH ET AL., CLIN CANC RES,, (2006), vol. 72, pages 6106 - 15-
DESCRIPTION- KHATTRI R ET AL., NAT IMMUNOL., (2003), vol. 4, pages 337 - 342-
DESCRIPTION- KLEBANOFF CA ET AL., TRENDS IMMUNOL, (2005), vol. 26, pages 111 - 117-
DESCRIPTION- KOBAYASHI M ET AL., J IMMUNOL., (2006), vol. 176, pages 6211 - 6218-
DESCRIPTION- KUHN ET AL., CELL, (1993), vol. 75, pages 263 - 274-
DESCRIPTION- KUHN R ET AL., CELL, (1993), vol. 75, pages 263 - 74-
DESCRIPTION- LAMERS CHJ ET AL., DANIEL DEN HOED CANCER NEWS, (2004), vol. 2, pages 8 - 10-
DESCRIPTION- LOSER K ET AL., GENE THER, (2005), vol. 12, pages 1294 - 1304-
DESCRIPTION- MANCEK M ET AL., BIOCHEM BIOPHYS RES COMM, (2002), vol. 2P2, pages 880 - 885-
DESCRIPTION- MANTINI MC ET AL., J IMMUNOL., (2004), vol. 72, pages 5149 - 5153-
DESCRIPTION- MAUL J ET AL., GASTROENTEROLOGY, (2005), vol. 128, no. 7, pages 1868 - 1878-
DESCRIPTION- MEAL DJ ET AL., PROC NATL ACAD SCI USA, (2005), vol. 102, pages 11817 - 11822-
DESCRIPTION- MILLER MJ ET AL., PROC NATL ACAD SCI USA, (2003), vol. 700, pages 2604 - 2609-
DESCRIPTION- MITSUYASU RT ET AL., BLOOD, (2000), vol. 96, pages 785 - 793-
DESCRIPTION- MIZOGUCHI A ET AL., INFLAMM BOWEL DIS., (2003), vol. 9, pages 246 - 259-
DESCRIPTION- MOMBAERTS ET AL., CELL, (1993), vol. 75, pages 274 - 282-
DESCRIPTION- MORRISSEY PJ ET AL., JEXP MED, (1993), vol. 178, pages 237 - 244-
DESCRIPTION- MOTTET C ET AL., J IMMUNOL, (2003), vol. 170, no. 8, pages 3939 - 3943-
DESCRIPTION- NEURATH ET AL., JEXP MED,, (1995), vol. 182, pages 1281 - 1290-
DESCRIPTION- PAVELIC ZP ET AL., ANTICANCER RES., (1991), vol. 11, pages 1671 - 1675-
DESCRIPTION- PIN THUS JHU ET AL., J CLIN INVEST, (2004), vol. 114, pages 1774 - 1781-
DESCRIPTION- PITCHER LA ET AL., TRENDS IMMUNOL., (2003), vol. 24, pages 554 - 560-
DESCRIPTION- PODOLSKY DK, N ENGL J MED, (2002), vol. 347, pages 417 - 429-
DESCRIPTION- POWRIE ET AL., IMMUNITY, (1994), vol. 1, pages 553 - 562-
DESCRIPTION- POWRIE F ET AL., JEXP MED., (1994), vol. 179, pages 589 - 600-
DESCRIPTION- PULE MA ET AL., MOL THER., (2005), vol. 12, pages 933 - 941-
DESCRIPTION- READ S ET AL., JEXP MED, (2000), vol. 192, pages 295 - 302-
DESCRIPTION- ROBERTS MR. ET AL., BLOOD, (1994), vol. 84, pages 2878 - 2889-
DESCRIPTION- ROSENBERG SA ET AL., NAT MED, (2004), vol. 10, pages 909 - 915-
DESCRIPTION- SAHA A ET AL., IMMUNOLOGY, (2006), vol. 118, pages 483 - 496-
DESCRIPTION- SAKAGUCHI S ET AL., IMMUNOL REV., (2006), vol. 272, pages 8 - 27-
DESCRIPTION- SAKAGUCHI S ET AL., J IMMUNOL, (1995), vol. 155, pages 1151 - 1164-
DESCRIPTION- SARTOR RB, CURR OPIN GASTROENTEROL., (2001), vol. 4, pages 324 - 330-
DESCRIPTION- SCHEININ, T ET AL., CLIN EXP IMMUNOL, (2003), vol. 133, pages 38 - 43-
DESCRIPTION- SCHWARTZ RH, ANNU REV IMMUNOL, (2003), vol. 21, pages 305 - 334-
DESCRIPTION- SMITHSON JE ET AL., J PATHOL., (1996), vol. 180, pages 146 - 151-
DESCRIPTION- SPENCER DM ET AL., GASTROENTEROL., (2002), vol. 722, pages 94 - 105-
DESCRIPTION- STANCOVSKI I ET AL., J IMMUNOL, (1993), vol. 151, pages 6577 - 6582-
DESCRIPTION- SURI-PAYER, E ET AL., J. IMMUNOL., (1998), vol. 160, pages 1212 - 1218-
DESCRIPTION- SURI-PAYER E; FRITZSCHING B, SPRINGER SEMIN IMMUNOPATHOL., (2006), vol. 28, pages 3 - 16-
DESCRIPTION- TARRANT ET AL., J IMMUNOL, vol. 161, pages 122 - 127-
DESCRIPTION- "The T-Body Approach: Redirecting T Cells with Antibody Specificity", ESHHAR, Z., Therapeutic Antibodies. Handbook of Experimental Pharmacology, SPRINGER-VERLAG, (2008), vol. 181, pages 329 - 342-
DESCRIPTION- THORNTON AM ET AL., J IMMUNOL, (2000), vol. 164, no. 1, pages 183 - 190-
DESCRIPTION- TSIRONI E ET AL., AM J GASTROENTEROL., (2004), vol. 99, pages 1749 - 1755-
DESCRIPTION- URAUSHIHARA ET AL., J IMMUNOL, (2003), vol. 171, pages 708 - 716-
DESCRIPTION- WALKER MR. ET AL., J CLIN INVEST., (2003), vol. 772, pages 1437 - 1443-
DESCRIPTION- WALKER MR. ET AL., PROC NATL ACAD SCI USA., (2005), vol. 702, pages 4103 - 4108-
DESCRIPTION- WANG HY ET AL., IMMUNITY, (2004), vol. 20, pages 107 - 118-
DESCRIPTION- WANG J ET AL., MOL THER, (2004), vol. 9, pages 577 - 586-
DESCRIPTION- WAN YR ET AL., PROC NATL ACAD SCI USA., (2005), vol. 102, pages 5126 - 5131-
DESCRIPTION- WEINBERG AD, TRENDS IMMUNOL, (2002), vol. 23, pages 102 - 109-
DESCRIPTION- WILLEMSEN RA ET AL., HUM IMMUNOL, (2003), vol. 64, pages 56 - 68-
DESCRIPTION- W. STROBER, ANNU. REV. IMMUNOL., (2002), vol. 20, pages 495 - 454-
DESCRIPTION- ZHANG ET AL., J. IMMUNOL., (2007), vol. 179, pages 4910 - 4918-
EXAMINATION- M. Divya Jyothi ET AL, "Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes", Nature Biotechnology, (20021111), vol. 20, no. 12, doi:10.1038/nbt758, ISSN 1087-0156, pages 1215 - 1220, XP055186333
EXAMINATION- NGUYEN P ET AL, "Antigen-specific targeting of CD8+ T cells with receptor-modified T lymphocytes", GENE THERAPY, NATURE PUBLISHING GROUP, GB, (20030401), vol. 10, no. 7, doi:10.1038/SJ.GT.3301932, ISSN 0969-7128, pages 594 - 604, XP002314391
OPPOSITION- Anonymous, "Regulatory T Cells (Tregs): Frequently Asked Questions", BD Biosciences, Technical Resources, (20101201), pages 1 - 4, XP093118550-
OPPOSITION- Anonymous, "What’s the difference between IBD and IBS?", aboutkidshealth.ca, (20110124), aboutkidshealth.ca, URL: https://www.aboutkidshealth.ca/article?contentid=3038&language=english#, XP093152997-
OPPOSITION- FANTINI MASSIMO C ET AL, "Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.", The Journal of Immunology, Williams & Wilkins Co., US, US , (20040501), vol. 172, no. 9, ISSN 0022-1767, pages 5149 - 5153, XP002521312-
OPPOSITION- FINNEY HELENE M , AKBAR ARNE N, LAWSON ALASTAIR D G, "Activation of resting human primary T cells with chimeric receptors: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCRzeta chain.", The Journal of Immunology, Williams & Wilkins Co., US, US , (20040101), vol. 172, no. 1, ISSN 0022-1767, pages 104 - 113, XP002420497-
OPPOSITION- Sakaguchi Shimon, N Sakaguchi, M Asano, M Itoh, M Toda, "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) - Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases", The Journal of Immunology, (19950101), vol. 155, pages 1151 - 1164, XP093118558-
OPPOSITION- SMITH EMMA L ET AL, "Splice variants of human FOXP3 are functional inhibitors of human CD4(+) T-cell activation", Cancer research, Wiley-Blackwell Publishing Ltd., GB, GB , (20061001), vol. 119, no. 2, doi:10.1111/j.1365-2567.2006.02425.x, ISSN 0019-2805, pages 203 - 211, XP002490944-
OPPOSITION- "T cell-mediated cytotoxicity", Janeway Jr. C A, Travers P., Walport M. et al., Immunobiology: The Immune System in Health and Disease. 5th edition, NCBI Bookshelf, Garland Science, (20010101), XP093118564-
OPPOSITION- Eshhar Z, "The T-body approach: redirecting T cells with antibody specificity.", Handbook of Experimental Pharmacology, SPRINGER VERLAG, BERLIN, DE, BERLIN, DE , (20080101), no. 181, doi:10.1007/978-3-540-73259-4, ISBN 978-3-642-14540-7, pages 329 - 342, XP009106856
OPPOSITION- Jayaraman Jayapriya, Mellody Michael P., Hou Andrew J., Desai Ruchi P., Fung Audrey W., Pham An Huynh Thuy, Chen Yvonne Y., Zhao Weian, "CAR-T design: Elements and their synergistic function", EBioMedicine, Elsevier BV, NL, NL , (20200801), vol. 58, doi:10.1016/j.ebiom.2020.102931, ISSN 2352-3964, page 102931, XP055835082
OPPOSITION- Linda J. Van Eldik, "The roles of inflammation and immune mechanisms in Alzheimer's disease", Alzheimer's & Dementia: Translational Research & Clinical Interventions, (20160601), vol. 2, no. 2, doi:10.1016/j.trci.2016.05.001, ISSN 2352-8737, pages 99 - 109, XP093152995
OPPOSITION- Friedmann-Morvinski, D. Eshhar, Z., "Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity", UPDATE ON CANCER THERAPEUTICS, ELSEVIER, AMSTERDAM, NL, NL , (20060301), vol. 1, no. 1, doi:10.1016/j.uct.2006.04.005, ISSN 1872-115X, pages 25 - 32, XP005580755
OPPOSITION- ESHHAR ZELIG ET AL, "Functional expression of chimeric receptor genes in human T cells", Journal of Immunological Methods, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM., NL, NL , (20010201), vol. 248, no. 1-2, doi:10.1016/S0022-1759(00)00343-4, ISSN 0022-1759, pages 67 - 76, XP002499221
OPPOSITION- M. Divya Jyothi, Richard A. Flavell, Terrence L. Geiger, "Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes", Nature Biotechnology, Gale Group Inc., (20021201), vol. 20, no. 12, doi:10.1038/nbt758, ISSN 10870156, pages 1215 - 1220, XP055186333
OPPOSITION- Poorebrahim Mansour; Mohammadkhani Niloufar; Mahmoudi Reza; Gholizadeh Monireh; Fakhr Elham; Cid-Arregui Angel, "TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential", Cancer Gene Therapy, Nature Publishing Group US, New York, New York, (20210302), vol. 28, no. 6, doi:10.1038/s41417-021-00307-7, ISSN 0929-1903, pages 581 - 589, XP037480506
OPPOSITION- Elinav, E. ; Waks, T. ; Eshhar, Z., "Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice", Gastroenterology, Elsevier Inc., US, US , (20080601), vol. 134, no. 7, doi:10.1053/j.gastro.2008.02.060, ISSN 0016-5085, pages 2014 - 2024, XP022756845
OPPOSITION- WALKER MINDI R ET AL, "De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20050315), vol. 102, no. 11, doi:10.1073/pnas.0407691102, ISSN 0027-8424, pages 4103 - 4108, XP002439090
OPPOSITION- MEKALA DIVYA J, ALLI RAJSHEKHAR S, GEIGER TERRENCE L, "IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4(+) CD25(+) T lymphocytes", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20050801), vol. 102, no. 33, doi:10.1073/pnas.0505445102, ISSN 0027-8424, pages 11817 - 11822, XP002499219
OPPOSITION- ESHHAR Z, ET AL, "Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19930115), vol. 90, no. 2, doi:10.1073/pnas.90.2.720, ISSN 0027-8424, pages 720 - 724, XP002579936
OPPOSITION- Zelig Eshhar, "ESGCT 2007 Invited Presentations", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (20071001), vol. 18, no. 10, doi:10.1089/hum.2007.1031, ISSN 1043-0342, pages 941 - 954, XP093152992
OPPOSITION- Eshhar Zelig, "From the Mouse Cage to Human Therapy: A Personal Perspective of the Emergence of T-bodies/Chimeric Antigen Receptor T Cells", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (20140901), vol. 25, no. 9, doi:10.1089/hum.2014.2532, ISSN 1043-0342, pages 773 - 778, XP093118555
OPPOSITION- Christian Dejaco; Christina Duftner; Beatrix Grubeck‐Loebenstein; Michael Schirmer, "Imbalance of regulatory T cells in human autoimmune diseases", Cancer research, Wiley-Blackwell Publishing Ltd., GB, GB , (20051222), vol. 117, no. 3, doi:10.1111/j.1365-2567.2005.02317.x, ISSN 0019-2805, pages 289 - 300, XP071275181
OPPOSITION- HORI S, NOMURA T, SAKAGUCHI S, "Control of regulatory T cell development by the transcription factor Foxp3", Science, American Association for the Advancement of Science, US, US , (20030214), vol. 299, no. 5609, doi:10.1126/science.1079490, ISSN 0036-8075, pages 1057 - 1061, XP002316905
OPPOSITION- GYOBU H, ET AL., "Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor", Cancer research, American Association for Cancer Research, US, US, (20040215), vol. 64, doi:10.1158/0008-5472.CAN-03-2780, ISSN 0008-5472, pages 1490 - 1495, XP003020171
OPPOSITION- Mekala, Et Al, "Immunotherapy of autoimmune encephalomyelitis with redirected CD4 + CD25 + T lymphocytes", Blood, (20050301), vol. 105, no. 5, doi:10.1182/blood-2004-09-3579, pages 2090 - 2092, XP055371008
OPPOSITION- FRIEDMANN-MORVINSKI DINORAH ET AL, "Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation", Blood, American Society of Hematology, US, US , (20050415), vol. 105, no. 8, doi:10.1182/blood-2004-09-3737, ISSN 0006-4971, pages 3087 - 3093, XP002499220
OPPOSITION- Abken Hinrich; Hombach Andreas; Heuser Claudia, "Immune response manipulation: Recombinant immunoreceptors endow T-cells with predefined specificity.", Current Pharmaceutical Design, Bentham Science Publishers, NL, NL , (20030901), vol. 9, no. 24, doi:10.2174/1381612033454289, ISSN 1381-6128, pages 1992 - 2001, XP009107012
OPPOSITION- Anja A. Kühl, "Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases", Frontiers in Immunology, Frontiers Media, Lausanne, CH, Lausanne, CH , vol. 6, doi:10.3389/fimmu.2015.00613, ISSN 1664-3224, XP093152996
OPPOSITION- Terrence L. Geiger, "The TCR ζ-Chain Immunoreceptor Tyrosine-Based Activation Motifs Are Sufficient for the Activation and Differentiation of Primary T Lymphocytes", The Journal of Immunology, Williams & Wilkins Co., US, US , (19990515), vol. 162, no. 10, doi:10.4049/jimmunol.162.10.5931, ISSN 0022-1767, pages 5931 - 5939, XP093152999
OPPOSITION- Hombach, Wieczarkowiecz, Marquardt, Heuser, Usai, Pohl, Seliger, Abken, "Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.", The Journal of Immunology, American Association of Immunologists, (20011201), vol. 167, no. 11, doi:10.4049/jimmunol.167.11.6123, ISSN 00221767, pages 6123 - 6131, XP055083123
OPPOSITION- N. M. Haynes, J. A. Trapani, M. W. L. Teng, J. T. Jackson, L. Cerruti, S. M. Jane, M. H. Kershaw, M. J. Smyth, P. K. Darcy, "Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation", The Journal of Immunology, Williams & Wilkins Co., US, US , (20021115), vol. 169, no. 10, doi:10.4049/jimmunol.169.10.5780, ISSN 0022-1767, pages 5780 - 5786, XP055341255
OPPOSITION- Andreas A. Hombach, David Kofler, Anja Hombach, Gunter Rappl, Hinrich Abken, "Effective Proliferation of Human Regulatory T Cells Requires a Strong Costimulatory CD28 Signal That Cannot Be Substituted by IL-2", The Journal of Immunology, Williams & Wilkins Co., US, US , (20071201), vol. 179, no. 11, doi:10.4049/jimmunol.179.11.7924, ISSN 0022-1767, pages 7924 - 7931, XP055662869
SEARCH- ESHHAR Z, "The T-body approach: redirecting T cells with antibody specificity.", HANDBOOK OF EXPERIMENTAL PHARMACOLOGY 2008, (2008), no. 181, ISSN 0171-2004, pages 329 - 342, XP009106856 [PX] 1-18 * the whole document *
SEARCH- FRIEDMANN-MORVINSKI ET AL, "Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity", UPDATE ON CANCER THERAPEUTICS, ELSEVIER, AMSTERDAM, NL, (20060301), vol. 1, no. 1, ISSN 1872-115X, pages 25 - 32, XP005580755 [A] 1-18 * the whole document *
SEARCH[ ] - ELINAV E ET AL, "Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice", GASTROENTEROLOGY 200806 US, (200806), vol. 134, no. 7, ISSN 0016-5085, pages 2014 - 2024, XP002499222
SEARCH- MEKALA DIVYA J ET AL, "IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4(+) CD25(+) T lymphocytes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200508), vol. 102, no. 33, ISSN 0027-8424, pages 11817 - 11822, XP002499219 [X] 1,3-18 * abstract * * Introduction, discussion *
SEARCH- "ESGCT 2007 Invited presentations", HUMAN GENE THERAPY, (20071001), vol. 18, no. 10, pages 941 - 954, XP002499247 [PX] 1-18 * Inv 27, "Antigen-Specific Regulatory T cells redirected with Chimeric receptor Cure Acute Colitis"; page 951 *
SEARCH- FRIEDMANN-MORVINSKI DINORAH ET AL, "Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation", BLOOD, (200504), vol. 105, no. 8, ISSN 0006-4971, pages 3087 - 3093, XP002499220 [A] 1-18 * abstract *
SEARCH- ABKEN HINRICH ET AL, "Immune response manipulation: Recombinant immunoreceptors endow T-cells with predefined specificity.", CURRENT PHARMACEUTICAL DESIGN, (2003), vol. 9, no. 24, ISSN 1381-6128, pages 1992 - 2001, XP009107012 [A] 1-18 * abstract * * page 1999, column RIGHT, paragraphs LAST,FULL,PARAGRAPH *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents